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DObjectives: Mitral valve (MV) repair rates have lagged despite reported superior outcomes in patients with
mitral regurgitation. The purpose of the present study was to evaluate the relationship between procedure
volume and the propensity for MV repair in a multi-institution, regional patient cohort.
Methods: Society of Thoracic Surgeons–certified patient records of those undergoing MV repair or MV
replacement (MVR) for moderate or severe mitral regurgitation were evaluated from 17 different centers
(2001-2011). The relationship between the annual hospital and surgeon volume and the propensity forMV repair
over MVR was analyzed using multivariable, mortality risk-adjusted models with restricted cubic splines.
Results: A total of 4194 patients were evaluated (MV repair, 2516; MVR, 1662). The median annual mitral
procedure volume was 54 operations for hospitals and 13 operations for surgeons. The overall MV repair rate
was 60%, with significant variations among hospitals (range, 35%-70%) and surgeons (range, 0%-90%).
The MVR patients presented with higher Society of Thoracic Surgeons Predicted Risk of Mortality scores
(6% vs 2%, P < .001). After adjustment for Predicted Risk of Mortality score, both annual hospital
(P ¼ .04) and surgeon (P<.0001) procedure volume were associated with the probability of MV repair. The
likelihood for MV repair correlated with an operative volume of 20 procedures annually. Among surgeons
and hospitals performing 20 mitral operations annually, MV repair rates were greater (73% vs 26% and
62% vs 37%, respectively, P<.001 for both).
Conclusions: Significant variation in the performance of MV repair over MVR for mitral regurgitation persists
in the modern surgical era. Average annual surgeon volume was more significantly associated with MV repair
rate than institutional volume, with an increased likelihood for performance of MV repair among surgeons
performing>20 procedures annually. In the upcoming era of percutaneous MV repair, surgeon volume and
expertise as a gatekeeper should dictate access to this technology and the decisions for the best approach to
MV repair. (J Thorac Cardiovasc Surg 2014;148:995-1004)Mitral valve (MV) surgery remains the standard of care for
severe mitral regurgitation (MR) (grade 3-4þ). The current
joint American College of Cardiology/American Heart
Association and European Society of Cardiology guidelines
reflect the clear benefit ofMV surgery overmedicalmanage-
ment for severe MR.1,2 Despite these recommendations,
only 50% of patients meeting the American College of
Cardiology/American Heart Association guidelines for
surgical treatment undergo surgery.3,4 Moreover,
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The Journal of Thoracic and CaMV replacement (MVR) for moderate to severe MR has
been demonstrated among hospitals and surgeons.5
Although the accumulated data have favored reduced
operative mortality and morbidity for MV repair over
MVR, including the recently published Cardiothoracic Sur-
gery Trials Network Severe Ischemic Mitral Regurgitation
randomized controlled trial,6 the overall performance of
MV repair appears underused. Recent nationwide estimates
have suggested usage of MV repair for functional MR of
approximately 40%.7 Although a few noteworthy reports
have been published describing both patient-level and
surgeon-related factors associated with the performance of
MV repair,5,7,8 additional multi-institution analyses using
rigorous risk adjustment modeling methods are warranted
to further characterize the individual influence of hospital
and surgeon mitral procedure volume on the propensity for
MV treatment allocation.
The purpose of the present study was to evaluate the
relationship between annual surgeon and hospital
procedure volume and the likelihood for MV repair in a
multi-institution, regional cohort of patients with moderaterdiovascular Surgery c Volume 148, Number 3 995
Abbreviations and Acronyms
ACSD ¼ Adult Cardiac Surgery Database
MR ¼ mitral regurgitation
MV ¼ mitral valve
MVR ¼ mitral valve replacement
PROM ¼ Predicted Risk of Mortality
RCS ¼ restricted cubic spline
STS ¼ Society of Thoracic Surgeons
VCSQI ¼ Virginia Cardiac Surgery Quality
Initiative
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Dto severeMR.We hypothesized that significant variations in
MV repair rates would be present among surgeons and
hospitals in the modern surgical era; the probability for
performance of MV repair over MVR would correlate
with the average annual surgeon and/or hospital volume;
and the effect of surgeon and hospital volume on the
propensity for performance of MV repair over MVR would
be independent of the effects of preoperative patient risk.METHODS
The Virginia Cardiac Surgery Quality Initiative (VCSQI) consists of 17
cardiac surgical centers within the Commonwealth of Virginia that hold
regular meetings to exchange and compare de-identified patient
information to improve cardiac surgical care, quality, and costs. VCSQI
centers perform approximately 99% of the Commonwealth’s cardiac
operations, contributing patient data to the Society of Thoracic Surgeons
(STS) Adult Cardiac Surgery Database (ACSD).
The present study was exempt from formal institutional review board
review at each participating hospital owing to the secondary analysis of
the VCSQI de-identified (absence of Health Insurance Portability and
Accountability Act patient identifiers) data registry and because the data
were collected for quality analysis and purposes other than research.
Patients and Data Acquisition
De-identified patient data were extracted from the VCSQI data registry
for the study period (January 1, 2001 to December 31, 2011). All records
included patients undergoing isolated MV repair or MVR for moderate
or severe MR (STS procedure type ‘‘MV repair’’ and ‘‘MV replacement’’).
Patients undergoing concomitant coronary artery bypass grafting, other
valve procedures, or arrhythmia ablation procedures were excluded. All
mitral procedures used standard open surgical approaches to MV surgery
with the use of cardiopulmonary bypass support. Patient preoperative
risk was assessed by the prevalence of patient comorbid disease, the degree
of MR, operative status, and individually calculated STS Predicted Risk of
Mortality (PROM) scores.
Measured Outcomes
The primary outcomes of interest included the risk-adjusted association
between the probability of MV repair and average annual surgeon and
hospital procedure volume. The secondary outcomes of interest included
variations in MV repair rates and mitral procedure volume among surgeons
and hospitals and the identification of a threshold volume at which MV
repair was more commonly performed over MVR, independent of the
baseline patient risk. The average annual procedure volume was calculated
for each surgeon and hospital according to the performance of operations996 The Journal of Thoracic and Cardiovascular Surgthroughout the entire study period. Standard STS clinical definitions for
all analyzed variables were used.9
Statistical Analysis
Descriptive statistics. All statistical analyses were designed to test
the null hypotheses that the average annual procedure volumewould not be
significantly associated with the likelihood for MV repair (vs MVR). All
study outcomes and data comparisons were established a priori before
data collection. Categorical variables are expressed as group percentages
and continuous variables as either themean standard deviation or median
and 25th, 75th percentile, depending on the overall variable distribution.
Univariate comparisons included either Pearson’s chi-square or Fisher’s
exact test for categorical variables and either independent-sample,
single–factor, analysis of variance for normally distributed data or the
Wilcoxon rank sum test for non-normally distributed data. Two-sided
P values were used to define variable associations.
Risk-adjusted regression models. Two separate multiple
regression models were first used to estimate the confounder-adjusted
associations between the probability of MV repair (vs MVR) and average
annual hospital (model 1) and surgeon (model 2) procedure volume for
patients undergoing isolated MV operations for moderate to severe MR.
The average annual procedure volumes for both individual surgeons
and hospitals were analyzed as continuous functions, using restricted
cubic spline (RCS) smoothing transformations to account for both linear
and nonlinear associations with the performance of MV repair. RCS
functions are beneficial, because they use all data points to estimate the
shape of the relationship between an exposure (STS PROM) and an
outcome (operative mortality). The use of RCS transformations,
therefore, provides a more robust method to determine whether nonlinear
relationships exist between a continuous variable and a dependent
outcome. The use of RCS forces the tails of a function to be linear, which
simplifies the representation. For RCS functions, procedures volumes
were analyzed using a total of 3 knots placed at the 5th, 50th, and
95th percentiles to define the tails of each function. The predicted
association between procedure volume and MV repair were adjusted
for the confounding effects of the preoperative patient risk profile (STS
PROM) and the effects of operations performed by different surgeons
(model 1) and at different hospitals (model 2) through the inclusion of
these variables as model covariates. The relative strength of the associa-
tion between the average annual procedure volume and probability for
MV repair (vs MVR) compared with other modeled factors was
determined by each factors’ likelihood ratio (Wald chi-square statistic)
within the model. In addition, the risk-adjusted RCS function for both
average annual surgeon and hospital procedure versus the probability
of MV repair was graphically represented to identify an apparent
threshold value (or inflection point) for procedure volume that correlated
with an increase in the likelihood for MV repair.
Risk-adjusted propensity matched analyses. To further
verify the multivariable model results for the estimated effects of the
average annual surgeon and hospital mitral procedure volume on the
probability of MV repair, additional risk-adjusted propensity score–
matched analyses were performed to compare the study cohorts of
matched MV repair and MVR. Propensity scores were estimated using
logistic regression modeling with performance of MV repair (vs MVR)
as the response variable and patient age, sex, operative year, surgeon,
hospital, operative status (elective, urgent, or emergency), operative
incidence (first operation or reoperation), and a history of endocarditis
or heart failure as possible confounding predictor variables. Propensity
scores were then used to match MV repair and MVR patients in a 1:1
ratio using the nearest neighbor greedy method, resulting in equal-size
study cohorts. The MV repair and MVR rates were then compared as a
function of the estimated volume thresholds and adjusted relationship
between the procedure volume, and likelihood for MV repair was
modeled within this cohort.ery c September 2014
TABLE 1. Frequency of preoperative patient risk factors for patients
undergoing mitral valve repair and replacement
Risk factor
MVR
(n ¼ 1662)
MV repair
(n ¼ 2516)
P
value
Patient age (y) 63.98  13.09 61.94  11.84 <.0001
Sex
Female 53.20 38.50 <.0001
Male 46.80 61.50
Cerebrovascular disease 16.10 9.60 <.0001
Chronic lung disease <.0001
None 74.80 83.80
Mild 12.30 9.30
Moderate 7.90 4.80
Severe 5.00 2.10
Diabetes 25.40 23.40 .15
Dyslipidemia 67.10 67.40 .86
Hypertension 67.00 63.50 .02
History of infective endocarditis 12.70 4.30 <.0001
Previous stroke 7.80 5.40 .002
Renal failure 7.20 4.20 <.0001
Renal failure (dialysis) 6.50 3.00 <.0001
Previous CABG 9.50 4.50 <.0001
Previous valve operation 14.90 1.10 <.0001
Arrhythmia 27.50 14.40 <.0001
NYHA classification <.0001
I 6.80 10.20
II 18.70 24.10
III 37.30 31.40
IV 23.30 15.10
Unknown 14.00 19.40
Heart failure within 2 wk 58.70 44.80 <.0001
Status <.0001
Elective 57.20 69.40
Urgent 37.00 29.30
Emergency 5.80 1.40
Incidence <.0001
First operation 78.30 94.30
Reoperation 1 19.40 5.40
Reoperation 2 1.70 0.20
Reoperation 3 0.50 0.00
Reoperation 4þ 0.00 0.10
Mitral valve insufficiency <.0001
Moderate 18.40 26.40
Severe 81.60 73.60
STS PROM (%) 5.6 (2.6, 11.6) 1.7 (0.5, 4.3) <.0001
Data presented as mean  standard deviation,%, or median (25th, 75th percentile).
MVR, Mitral valve replacement; MV, mitral valve; CABG, coronary artery bypass
grafting; NYHA, New York Heart Association; STS, Society of Thoracic Surgeons;
PROM, Predicted Risk of Mortality.
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assessed using the C statistic and the Nagelkerke pseudo-R2 statistic. The
C statistic is equivalent to the area under the receiver operating character-
istic curve for models with a dichotomous response variable. It provides an
estimate of the model’s ability to discriminate between observed instances
of MV repair versus MVR. The Nagelkerke pseudo-R2 statistic is a
log-likelihood ratio chi-square–based measure analogous to the R2 statistic
in ordinary multiple regression. The Nagelkerke pseudo-R2 statistic
theoretically changes from 0 for models that provide no predictive
information to 1 for models that predict perfectly and describes the degree
of variance in the response variable (MV repair) explained by the model.
All statistical analyses were conducted using R statistical software, version
3.0.2 (available at: http://www.R-project.org).
RESULTS
Patient Characteristics and Operative Features for
MV Operations
A total of 4194 patients underwent MV procedures for
moderate to severe MR during the study period, including
2516 (60%) MV repair and 1662 (40%) MVR operations.
The descriptive statistics and frequencies of patient risk
factors are listed in Table 1. Overall, patients undergoing
MVR presented with greater preoperative risk (STS
PROM, 5.6% vs 1.7%, P < .0001). Comorbid disease
was more prevalent among the MVR patients, including
cerebrovascular disease, chronic lung disease, hypertension
(P ¼ .02), history of endocarditis, previous stroke
(P ¼ .002), renal failure and hemodialysis, arrhythmia,
heart failure, and advanced New York Heart Association
class (P<.001 for all others). In addition, the MVR patients
more commonly underwent a greater proportion of cardiac
reoperations and urgent or emergency operations (P<.001).
Severe MR was also slightly more common among patients
undergoing MVR (81.6% vs 73.6%, P<.0001).
Distribution of Hospital and Surgeon Volumes and
MV Repair and MVR Rates
Significant variation in hospital and surgeon MV
procedure volumes and rates of MV repair were observed
throughout the study period. The median annual mitral
procedure volume was 54 operations annually for hospitals
and 13 operations annually for surgeons. Figure 1 displays
the distribution of the median annual MV procedure volume
for hospitals (Figure 1, A) and surgeons (Figure 1, B).
As expected, both hospital and surgeon volumes were not
normally distributed. Moreover, the overall MV repair
rate was 60%, with significant variations among the
hospitals (range, 35%-70%; P < .0001; Figure 2) and
surgeons (range, 0%-90%; P<.0001; Figure 3).
Adjusted Relationship Between Probability of MV
Repair and MV Procedure Volume
To determine the risk-adjusted relationship between the
annual hospital and surgeon MV procedure volumes and
the likelihood of MV repair, logistic regression modeling
was performed. Considering the non-normal distributionThe Journal of Thoracic and Caof each volume measure, the likelihood for MV repair
was modeled as a function of both annual hospital (model
1) and surgeon (model 2) procedure volume with restricted
cubic spline transformations as both linear and nonlinear
terms (Table 2). The estimated associations were adjusted
for the confounding influence of preoperative patient risk
using STS PROM (with RCS transformations) and the
influence of the individual surgeon (model 1) or hospitalrdiovascular Surgery c Volume 148, Number 3 997
FIGURE 1. Histograms displaying the distribution of median annual mitral valve procedure volume for (A) hospitals and (B) surgeons.
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hospital (P ¼ .03) and surgeon (P<.0001) MV procedure
volume and the propensity for MV repair were significant.
Annual surgeon volume demonstrated a much greater
strength of association with the propensity for MV repair
(likelihood ratio, 59.89). More importantly, the adjusted
spline function revealed that an annual surgeon volume of
>20 operations/y was associated with an increasing
probability of MV repair, with dramatically increasing
probabilities for surgeons performing >20 operations/y
within both the entire patient cohort (Figure 4, A) and the
propensity matched patient cohort (Figure 4, B).
The statistical performance of this regression models
achieved adequate discrimination, with a C statistic
of 0.78 and 0.81. The models explained 25% and 31%
of the variance in the MV repair rates, as reflectedFIGURE 2. Comparison of hospital variation in m
998 The Journal of Thoracic and Cardiovascular Surgby a Nagelkerke pseudo-R2 value of 0.25 and 0.28,
respectively.
Comparison of MV Repair as a Function of
Procedure Volume Threshold
After empirically testing the adjusted relationship
between the performance of MV repair and annual
procedure volume, a threshold value of>20 operations/y
was identified and further evaluated to determine the effect
of MV procedure choice. Overall, among surgeons and
hospitals performing 20 mitral operations annually, the
MV repair rates were greater (73% vs 26% and 62% vs
37%, respectively; P<.001, for both).
To further validate the estimated associations described
by models 1 and 2, we examined the rates of MV repair
with respect to the observed threshold of>20 operationsitral valve procedure rates. MV, Mitral valve.
ery c September 2014
FIGURE 3. Variation in surgeon mitral valve repair rates.
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repair (n ¼ 1661) and MVR (n ¼ 1661) patients. Similar
observations were noted in the propensity matched cohort
of patients, with significantly greater rates of MV repair
for hospitals and surgeons performing >20 operations
annually (53% vs 47% and 67% vs 39%, respectively,
P<.0001 for both).Comparison of Postoperative Outcomes for MV
Repair and MVR
The incidence of postoperative outcomes and hospital
length of stay for propensity matched MV repair versusTABLE 2. Multivariable regression results for the modeled outcome
of likelihood of mitral valve repair (vs replacement) and its
association with the influence of annual hospital (model 1) and
surgeon (model 2) mitral procedure volume
Factor
Likelihood
ratio (Wald
statistic) AOR (95% CI)
P
value
Model 1
Annual hospital volume
(nonlinear)*
4.32 1.23 (1.02-1.48) .03
PROM (nonlinear)* 96.05 0.15 (0.12-0.18) <.0001
Surgeon 0.39 0.95 (0.80-1.13) .53
Model 2
Annual surgeon volume
(nonlinear)*
59.89 1.25 (1.04-1.72) <.0001
PROM (nonlinear)* 77.26 0.17 (0.13-0.21) <.0001
Hospital 0.09 0.98 (0.84-1.13) .77
Each model adjusted influence of all covariate factors; model 1 performance
characteristics, C-statistic, 0.78; Nagelkerke pseudo-R2¼ 0.25; model 2 performance
characteristics, C-statistic, 0.81; Nagelkerke pseudo-R2 ¼ 0.31. AOR, Adjusted odds
ratio; CI, confidence interval; PROM, Predicted Risk of Mortality. *Transformation
of continuous variable using restricted cubic spline piecewise polynomial smoothing
functions (3 knots at 5th, 50th, and 95th percentiles).
The Journal of Thoracic and CaMVR patient populations are listed in Table 3. Patients
undergoing MV repair were associated with lower rates
of postoperative morbidity and 30-day and operative
mortality.DISCUSSION
The present study reports on the performance of MV
operations in a statewide patient population with moderate
to severe MR. The reported findings address the funda-
mental question related to the risk-adjusted influence of
hospital and surgeon volume and/or experience on the
likelihood for performance of MV repair. The present
investigation has demonstrated that significant variation
exists in the modern surgical era in the performance of
MV repair at both the hospital and the individual surgeon
level. These differences also appeared to be more strongly
related to individual surgeon factors. Thus, with emerging
percutaneous techniques for mitral repair, these data
have demonstrated the critical role of the surgeon in the
procedure choice for MR.
The 60% rate of the performance of MV repair in the
present series demonstrated an improvement compared
with previous reports. Previous single-institution and
nationwide analyses have suggested an underusage of
surgical MV repair in the setting of reported superior
perioperative outcomes compared with MVR, including
preservation of the left ventricular function, freedom from
anticoagulation therapy, and lower early and late mortal-
ity.5,7,8,10-12 A clinically important estimate of nationwide
rates of MV repair were provided by separate analyses of
the STS ACSD by Gammie and colleagues5 and Bolling
and colleagues,7 which demonstrated MV repair rates of
42% to 61% (from 2000 to 2007) and 41%, respectively.rdiovascular Surgery c Volume 148, Number 3 999
FIGURE 4. Plot of adjusted association between probability of mitral valve repair and the adjusted restricted cubic spline function for average annual
surgeon mitral procedure volume within (A) the entire patient cohort and (B) a propensity matched patient group. MV, Mitral valve; PROM, Predicted
Risk of Mortality.
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overall improvement compared with the 38% mitral repair
rate reported in the United States from 1999 to 2000.12
Furthermore, the present study has demonstrated important
variations in MV repair rates across hospitals, with MV
repair rates ranging from 38% to 70%, and among
surgeons. Some surgeons exclusively performed MVR
(ie, 0% MV repair rate), and others performed MV repair
in 90% of cases. These observations have potentially
important clinical implications related to the influence of
underlying mitral etiology and how such differences might
affect referral for repair or replacement and individual
surgeon MV procedure choice. Thus, 1 consideration in
this and many analyses of MV operations using currentlyTABLE 3. Postoperative outcomes for propensity matched patients
undergoing mitral valve repair versus replacement
Outcome
MV repair
(n ¼ 1661)
MVR
(n ¼ 1661) P value
Postoperative LOS (d) 6 (4, 8) 8 (6, 8) <.001
Myocardial infarction 0.4 0.5 .59
Stroke 1.3 2.3 .04
New-onset atrial fibrillation 22.2 23.2 .48
Pneumonia 2.6 6.9 <.001
Renal failure 4.5 9.6 <.001
New-onset hemodialysis 1.6 4.7 <.001
30-d mortality 2.1 5.8 <.001
Operative mortality 2.6 6.8 <.001
Data presented as median (25th, 75th percentile) or%.MV, Mitral valve;MVR, mitral
valve replacement; LOS, length of stay.
1000 The Journal of Thoracic and Cardiovascular Suravailable cardiac surgery clinical databases, including the
national STS ACSD, concerns the granularity that exists
in the data regarding the etiology of MV disease. Without
these details, it is difficult to completely appreciate which
valves are appropriate for MV repair and which are
amenable to MVR alone. This aspect of confounding
certainly influences surgeon treatment allocation for MV
disease. We are encouraged by the current steps taken by
the STS to begin capturing more robust data related to
MV etiology in its most recent data harvesting efforts, and
we believe that future analyses will be able to better address
these concerns when these data are available.
The principal findings of the present study concern the
estimated associations observed between the average
annual surgeon and hospital MV procedure volume and
the likelihood for MV repair (vs MVR) after adjustment
for the confounding influence of baseline patient risk. The
independent examination of both hospital and surgeon
procedure volume measures was considered, because both
these metrics have been evaluated in previous investigations
and have been advanced as potential quality performance
measures for hospitals and surgeons performing MV
operations by some investigators.5,7 As a result, these
data demonstrated significant associations between each
volume measure and the adjusted probability of MV
repair compared with MVR. The strength of association,
however, was much stronger and highly significant for
the influence of the average annual surgeon volume
than for the hospital volume, as indicated by their
respective model likelihood ratios (59.89 vs 4.32). Thesegery c September 2014
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and colleagues,7 who demonstrated that increased
surgeon-level MV volume was independently associated
with an increased propensity for MV repair, including
estimates that surgeons performing >100 mitral cases
annually were 3 times more likely to perform MV repair
(vs MVR) than surgeons performing<5 MV cases annually
(adjusted odds ratio, 3.78).7 The relationship between
hospital procedure volume and the probability for MV
repair was not nearly as robust after accounting for the
influence of individual surgeon in the present analyses.
Thus, it appeared that the hospital MV volume likely serves
as a surrogate or proxy for the influence of surgeon volume
and experience in relation to MV surgery.
The questions and implications of volume thresholds and
the likelihood for the performance of either MV repair or
MVR are one of ongoing investigation and debate. The
findings in the present study have demonstrated that an
inflection point appears at average annual surgeon volumes
of approximately20 operations/y, at which the probability
for MV repair increases dramatically (Figure 4, A and B).
From these empiric results, we subsequently compared
the MV repair rates for categories of surgeons performing
<20 mitral operations/y with those performing 20 opera-
tions/y and found that the greater volume cohort of surgeons
was 3 to 4 times more likely to perform MV repair (vs
MVR) than surgeons performing<20 mitral operations/y.
These data are complimentary to the few published reports
that addressed the volume-outcome relationship that exists
for the performance of MV repair. In the previously
described work by Bolling and colleagues,7 an apparent
threshold of approximately 40 to 50 mitral operations/y
was noted at which the probability of MV repair became
more constant at approximately 70%. Other MV repair vol-
ume thresholds that have been advanced in the available
studies included the recommendations by Bridgewater
and colleagues10 for surgeon volumes of 25 repairs/y and
hospital volumes of 50 repairs/y, which were arbitrarily
defined thresholds extrapolated from volume-outcome rela-
tionships described in other surgical populations.
Unexpected in the present analyses was the observation
that a small percentage of the lowest volume surgeons
demonstrated an increased propensity to performMV repair
operations. Although definitive conclusions regarding these
observations could not be made from these analyses alone,
post hoc analyses demonstrated that the lowest volume sur-
geons with an average annual MVoperation rates of 0 to 5
cases/y (18% of surgeons) performed operations on highly
selected patients with a low STS PROM (1.5%) and
exclusively moderate MR. It is also plausible that this
subgroup of surgeons might represent young, relatively
inexperienced surgeons who benefitted from the senior
mentorship of more experienced, higher volume surgeons
and influenced the choice for MV repair. AdditionalThe Journal of Thoracic and Carprospective investigation within the VCSQI organization
is needed to draw more clear conclusions on these trends.
Critical to understanding the implications of the results of
the present study are the risk-adjustment modeling
techniques used to analyze the relationship between
volumemeasures and the adjusted probability ofMV repair.
Although other reports have been published that used
multivariable regression modeling for the investigation of
the relationship between volume measures and the relative
likelihood MV repair (vs MVR), the methods used in the
present analysis were unique in that the present study
did not focus on the contribution of other individual
patient-related clinical characteristics and did not arbitrarily
categorize the volume measures. The individual relation-
ship of patient characteristics on the propensity for MV
repair has been rather well established.5,7 In these
analyses, the influence of patient-level risk was accounted
for in aggregate using the widely accepted STS PROM
score, yielding well-adjusted models for patient risk.
More importantly, in the present analyses, we used
restricted cubic spline transformations of each volume
measure and the STS PROM variable to represent a more
accurate and robust approach to modeling each
continuous function. The techniques used in these analyses
most accurately characterized the linear and nonlinear
components that can exist in the relationship between
hospital and surgeon volume and the likelihood of MV
repair.13,14 An alternative approach used in previous
cardiac surgical reports is the arbitrary categorization of
volume measures into discrete categories (ie, quartiles,
quintiles).5,7,10,11,15-17 Such an approach results in the
conversion of continuous data (ie, surgeon volume) into
categorical data, perhaps resulting in a crucial loss of
information.13 The categorization of continuous volume
measures is problematic because this technique discards
information intrinsic to the original volume measure and
arbitrarily selects cutpoints for defining categories and
deriving conclusions.18 The ultimate result is a loss of
explanatory power because the modeled effect of that
variable is flat across the range of values included in that
category. The results of the present series, therefore, serve
to not only corroborate the volume-outcome association
that exists between surgeon volume and likelihood for
MV repair, but also to extend the examination of these
results to provide a more precise description of the
relationship of surgeon and hospital volume and the relative
likelihood of performance of MV repair (vs MVR).
The reported findings have significant surgeon- and
healthcare system-related implications. The present find-
ings add to an increasing body of data addressing an
apparent association between increasing surgeon procedure
volume and the increased likelihood of MV repair
compared with MVR. Our findings further promote the
concept of the ‘‘referent surgeon’’ first forwarded bydiovascular Surgery c Volume 148, Number 3 1001
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DMcCarthy.11 It is possible that referring cardiologists recog-
nize centers of excellence and expert surgeons for MV
repair and selectively refer candidates for MV repair to
these centers and surgeons, and other valves deemed appro-
priate for MVR might be referred to surgeons and hospitals
with lower MV repair rates. Recent trends in medicine and
surgery have focused on risk-adjusted outcome reporting
and the use of volume measures as a proxy for institution
and provider quality. These results can be extrapolated
to extend former recommendations by Gammie and
colleagues5 that performance ofMV repair (vsMVR), espe-
cially for functional MR, should be considered a potential
future performance measure within the cardiac surgical
and cardiovascular medicine communities.5 Finally, these
results highlight the critical importance of the role of the in-
dividual surgeon in the treatment allocation choice for the
treatment of mitral disease. In the rapidly approaching era
of percutaneous MV repair, surgeon volume and expertise
as a gatekeeper should dictate access to this technology.
A fundamental challenge encountered in the present
analysis, and one not addressed in previous STS ACSD an-
alyses, is the lack of clinical and diagnostic data related to
the valve morphology and etiology underlying MR. Thus,
it is difficult in the current era to use multi-institution STS
data registries to provide detailed estimates of which MVs
remain candidates for MV repair and to match the compar-
isons in analyses. Current and ongoing efforts by the STS to
expand the granularity of the collected data related to MV
disease and operative characteristics will likely allow
more robust analyses in the near future.
The limitations of the present study included the second-
ary analysis of a data registry and the observational nature
of the VCSQI and STS ACSD. The study design was retro-
spective and subject to inherent selection bias. The reported
results describe observed associations without assessing
direct cause and effect relationships. The de-identified
nature of the data further limited the ability to scrutinize
hospital- and surgeon-specific details. The variance attrib-
uted to the unique characteristics of participating VCSQI
hospitals could not fully be accounted for in the statistical
analysis. In addition, the reported findings represent
short-term, operative outcomes; intermediate- and long-
term follow-up data were not available. Finally, the
potential for unrecognized miscoding of data could have
had an immeasurable effect on the reported results, which
might have served to bias the results toward the null and
further underestimated the magnitude of the association
between volume measures and the modeled outcome, MV
repair (vs MVR).
CONCLUSIONS
A significant variation in the performance of MV repair
compared with MVR for moderate to severe MR persists
in the modern surgical era. The average annual surgeon1002 The Journal of Thoracic and Cardiovascular Survolume appeared more significantly associated with an
increased likelihood for MV repair than institutional
volume. An increased propensity for the performance of
MV repair appears to exist for surgeons performing
>20 MV procedures annually. These results could have
important future implications on patient referral of care
and quality measure assessment. In the upcoming era of
percutaneous MV repair technology, surgeon volume and
expertise as a gatekeeper should dictate access to this
technology and the decisions for the best approach to MV
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DDiscussion
Dr David A. Fullerton (Aurora, Colo). Thank you very much.
Dr LaPar, I very much enjoyed your presentation and enjoyed
reading your report even more. It is extremely well written, and
it will be an excellent contribution to the data further defining
the relationship of surgeon volume and hospital center volume in
mitral valve surgical outcomes and the choice of operation.
I must confess that the sophisticated statistical method that you
used is a little over my head. I do not question it. I just have to
acknowledge up front that I do not fully understand it, and I
suspect that many who read the report will likewise have similar
questions. It is for that reason that I have a single question for
you. You have done a very nice job of demonstrating a threshold
of about 20 cases annually as being important in the surgeon’s
volume for defining, if you will, the percentage of mitral
valvuloplasties that are performed in that surgeon’s hands as
opposed to replacements. Yet, as one looks at the final graphs
that you displayed, one can see that even those surgeons who
have very low volumes per annum have identical rates of repair
as those that have very high rates or very high surgical volumes.
So I am curious as to how you might think this 20 cases per year
might actually play a role, and how might you help explain, then,
that even those centers and those surgeons with very low volumes
actually had very high rates of repair?
Thank you very much, and I enjoyed your report.
Dr LaPar. Thank you very much, Dr Fullerton, for those
questions and your kind comments.
The threshold that we observed of approximately 20 mitral
operations per year and the relationship to performance of mitral
repair is complimentary to several previous reports that have
examined trends in mitral surgery.
We, too, were surprised by the findings that the probability of
performing mitral operations was somewhat higher among very
low-volume surgeons performing between 0 and 5 operations
per year. We’re not quite sure exactly what motivations account
for this trend and unfortunately can’t draw any definitive
conclusions on this trend at this point without looking into the
practice patterns of these hospitals a little more closely.
When we looked into the data available to us for this study for
this subgroup of patients, we did notice some interesting trends
that are somewhat descriptive. We found that these patients had
very low predicted risk of mortalities—less than 1.2% for most
of them. We also found that these patients tended to have almost
exclusively moderate mitral regurgitation.
These findings may also represent the experience of relatively
young surgeons receiving senior mentorship for mitral repair at
some centers, but, because of the de-identified nature of this
data, this is truly speculative at this point.
Dr Lawrence H. Cohn (Boston, Mass). I just want to ask you
an obvious question. Is this type of study going to lead to the state
of Virginia dictating who and who will not be able to perform
mitral valve surgery in the future?The Journal of Thoracic and CarDr LaPar. That is certainly is an important question. I don’t
think it’s going to have too many direct policy implications
regarding treatment allocation in the state of Virginia, but I think
it does generally support what we’ve seen in the national data:
That surgeons who have expertise in certain areas are more likely
going to perform mitral repairs where appropriate.
Dr W. Randolph Chitwood (Greenville, NC). Damien, I
thought this was a great study, and it sort of parallels some of
the work that Jim Gammie did in the past. But the 1 point it
does not state, and neither does Jim Gammie’s report or any of
these reports, is what about the repairable valves? In other words,
repairable versus rheumatic versus, let us say, you are in a small
hospital and you have 15 cases coming in there, are these all
posterior leaflet P2 resections, which are fairly straightforward
and most can be repaired, or are they anterior leaflet resections?
So I think we must sometime study the data in our databases in
depth to know exactly what we are repairing and what we are not.
Because I would expect if you take the low-volume surgeons and
the low-volume centers with good results, that they are being smart
enough to take on the straightforward posterior leaflet cases, which
are 80% of the degenerative disease cases, and what about those
with rheumatic valves?
So your database, I do not believe separates this nor does our
national database. Thus, this is a cry, wouldn’t you say, especially
when Dave Adams presented a report yesterday about
guidelines and items of this nature. Because I guarantee you the
members of this organization, the European Association for
Cardio-Thoracic Surgery, and the STS would be up in arms if
someone mandated that one cannot repair a MV unless you have
done 25 MV repairs because some people do achieve excellent
results. So, comment on the pathophysiology.
Dr LaPar. I couldn’t agree more with you that a fundamental
limitation of a regional dataset like this, but also within the STS
national data, is a lack of information related to mitral valve etiol-
ogy and pathology. And, as you are aware, it is something that the
STS is really trying to improve in the new data-harvesting efforts.
Unfortunately, in this data, we can’t tease that out either in this
data because this is an analysis of a regional STS database.
Dr Chitwood. The sin is in your propensity matched patients,
only 50% were repaired. The European data show more. But still,
if you are considering repairable valves, almost 100% should be
repaired.
Dr Daniel H. Drake (Traverse City, Mich). I direct the
Michigan Society of Thoracic and Cardiovascular SurgeonsMitral
Initiative. I enjoyed your presentation immensely.
In Michigan, we have started to see internal referrals between
Society surgeons. The complexity of repair can be predicted
from the diagnostic transesophageal echocardiogram. After a
review of the transesophageal echocardiogram (which is
performed well in advance of surgery), and depending on the
individual surgeon’s level of comfort and expertise, we have
occasionally seen referrals between surgeons. This was somewhat
unanticipated and is an interesting process to observe. Are you
seeing similar referrals between surgeons? Also, what are your
efforts to predict complexity?
Dr LaPar. I am sorry, what was the last part?
Dr Drake. What are your efforts toward predicting the
complexity of repair?diovascular Surgery c Volume 148, Number 3 1003
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C
DDr LaPar. You question is quite interesting because we
haven’t been able to empirically examine the trends within our
organization for internal referrals.
Dr Drake. How about the discussion during your collaborative
meetings? Do the surgeons seem at all interested in referral among
themselves?1004 The Journal of Thoracic and Cardiovascular SurDr LaPar. The VCSQI certainly is interested in developing
processes of care that result in the delivery of the best patient
care. Although we haven’t directly discussed the trends of internal
referrals for mitral repair, this is certainly something that may look
into further in future collaborations.
Dr Drake. Thank you.gery c September 2014
